AstraZeneca PLC (NASDAQ:AZN)
| 47.16 Delayed Data As of 4:14pm ET |  -0.57 / -1.19%Today’s Change | 36.15 Today|||52-Week Range 64.94 | -5.66% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 47.73 |
| Today’s open | 47.63 |
| Day’s range | 46.85 - 47.63 |
| Volume | 1,935,863 |
| Average volume (3 months) | 10,493,180 |
| Market cap | $127.0B |
Data as of 4:14pm ET, 03/03/2021
Growth & Valuation
| Earnings growth (last year) | +138.26% |
| Earnings growth (this year) | +31.03% |
| Earnings growth (next 5 years) | +16.95% |
| Revenue growth (last year) | +9.55% |
| P/E ratio | 38.7 |
| Price/Sales | 4.89 |
| Price/Book | 8.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | -1.22 | -1.68% |
| SNYSanofi | -0.46 | -1.00% |
| BMYBristol-Myers Squibb | -0.52 | -0.84% |
| GSKGlaxoSmithKline | +0.15 | +0.44% |
Data as of 4:00pm ET, 03/03/2021
Financials
| Next reporting date | April 30, 2021 |
| EPS forecast (this quarter) | $0.55 |
| Annual revenue (last year) | $26.8B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 12.01% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
